Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

por Chrétien, Sebastian, Zerdes, Ioannis, Bergh, Jonas, Matikas, Alexios, Foukakis, Theodoros
Publicado no Cancers (Basel) (2019)

Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations

por Zerdes, Ioannis, Matikas, Alexios, Bergh, Jonas, Rassidakis, George Z., Foukakis, Theodoros
Publicado no Oncogene (2018)

Plasmablastic Lymphoma with Coexistence of Chronic Lymphocytic Leukemia in an Immunocompetent Patient: A Case Report and Mini-Review

por Hatzimichael, Eleftheria, Papathanasiou, Konstantina, Zerdes, Ioannis, Flindris, Stefanos, Papoudou-Bai, Alexandra, Kapsali, Eleni
Publicado no Case Rep Hematol (2017)

SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12

por González-Rodríguez, Patricia, Engskog-Vlachos, Pinelopi, Zhang, Hanzhao, Murgoci, Adriana-Natalia, Zerdes, Ioannis, Joseph, Bertrand
Publicado no Cell Death Dis (2020)

Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence

por Boussios, Stergios, Zerdes, Ioannis, Batsi, Ourania, Papakostas, Vasilios P., Seraj, Esmeralda, Pentheroudakis, George, Glantzounis, George K.
Publicado no Int J Surg Case Rep (2016)

The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?

por Katsi, Vasiliki, Georgountzos, Georgios, Kallistratos, Manolis S., Zerdes, Ioannis, Makris, Thomas, Manolis, Athanasios J., Nihoyannopoulos, Petros, Tousoulis, Dimitris
Publicado no Front Pharmacol (2017)

Extranodal diffuse large B-cell lymphomas: A retrospective case series and review of the literature

por Boussios, Stergios, Zerdes, Ioannis, Vassou, Amalia, Bareta, Eleni, Seraj, Esmeralda, Papoudou-Bai, Alexandra, Pavlidis, Nicholas, Batistatou, Anna, Pentheroudakis, George
Publicado no Hematol Rep (2018)

PD-1 protein and gene expression as prognostic factors in early breast cancer

por Matikas, Alexios, Zerdes, Ioannis, Lövrot, John, Sifakis, Emmanouil, Richard, Francois, Sotiriou, Christos, Rassidakis, Georgios, Bergh, Jonas, Valachis, Antonis, Foukakis, Theodoros
Publicado no ESMO Open (2020)

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen recep...

por Zerdes, Ioannis, Sifakis, Emmanouil G., Matikas, Alexios, Chrétien, Sebastian, Tobin, Nicholas P., Hartman, Johan, Rassidakis, George Z., Bergh, Jonas, Foukakis, Theodoros
Publicado no Mol Oncol (2020)

STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer

por Zerdes, Ioannis, Wallerius, Majken, Sifakis, Emmanouil G., Wallmann, Tatjana, Betts, Stina, Bartish, Margarita, Tsesmetzis, Nikolaos, Tobin, Nicholas P., Coucoravas, Christos, Bergh, Jonas, Rassidakis, George Z., Rolny, Charlotte, Foukakis, Theodoros
Publicado no Cancers (Basel) (2019)

Immune gene expression and response to chemotherapy in advanced breast cancer

por Foukakis, Theodoros, Lövrot, John, Matikas, Alexios, Zerdes, Ioannis, Lorent, Julie, Tobin, Nick, Suzuki, Chikako, Brage, Suzanne Egyházi, Carlsson, Lena, Einbeigi, Zakaria, Linderholm, Barbro, Loman, Niklas, Malmberg, Martin, Fernö, Mårten, Skoog, Lambert, Bergh, Jonas, Hatschek, Thomas
Publicado no Br J Cancer (2018)

Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial

por Hatschek, Thomas, Foukakis, Theodoros, Bjöhle, Judith, Lekberg, Tobias, Fredholm, Hanna, Elinder, Ellinor, Bosch, Ana, Pekar, Gyula, Lindman, Henrik, Schiza, Aglaia, Einbeigi, Zakaria, Adra, Jamila, Andersson, Anne, Carlsson, Lena, Dreifaldt, Ann Charlotte, Isaksson-Friman, Erika, Agartz, Susanne, Azavedo, Edward, Grybäck, Per, Hellström, Mats, Johansson, Hemming, Maes, Claudia, Zerdes, Ioannis, Hartman, Johan, Brandberg, Yvonne, Bergh, Jonas
Publicado no JAMA Oncol (2021)